BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
glucose metabolic process
,
Obesity
,
Neuron
,
Metabolism of nitric oxide
,
Clofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tyrosine-protein kinase, receptor class II, conserved site
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Tongue superior part with papillae
Tonsil
B lymphocyte (naive) of spleen
Spleen
B lymphocyte (IgM memory) of spleen
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Adrenoleukodystrophy
Vesicular stomatitis Indiana virus disease
Pyloric ulcer
Bovine respiratory syncytial virus disease
Anomaly of chromosome pair 11
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
CP 466722
GSK-1059615
Apitolisib
CGP 60474
HG-14-10-04
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SHANK3
PDE6B
NR5A1
CRKL
NANOGP8
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Tyrosine-protein kinase, receptor class II, conserved site
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-P…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ